The Manufacturers Life Insurance Company Has $3.24 Million Stake in Maximus, Inc. $MMS

Key Points

• The Manufacturers Life Insurance Company cut its Maximus stake by 85.2% in the first quarter, selling 291,726 shares and retaining 50,540 shares valued at approximately $3.24 million. Institutional investors collectively own 97.21% of MMS.
• Maximus reported fiscal Q3 adjusted EPS of $2.22, slightly above estimates, but revenue fell 5.1% year over year to $1.28 billion, below consensus. The company lowered fiscal 2026 EPS guidance to $7.90–$8.20.
• Analysts have converged on a “Hold” consensus rating after several downgrades. Maximus also declared a quarterly dividend of $0.33 per share, representing a 2.2% annualized yield.

The Manufacturers Life Insurance Company reduced its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 85.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,540 shares of the health services provider's stock after selling 291,726 shares during the quarter. The Manufacturers Life Insurance Company owned 0.10% of Maximus worth $3,240,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in MMS. Seizert Capital Partners LLC acquired a new stake in Maximus in the 4th quarter valued at about $1,863,000. Ruffer LLP bought a new position in Maximus during the fourth quarter worth about $6,951,000. UBS Group AG increased its position in Maximus by 76.8% during the fourth quarter. UBS Group AG now owns 610,354 shares of the health services provider's stock worth $52,686,000 after buying an additional 265,095 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Maximus by 7.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider's stock valued at $135,084,000 after buying an additional 141,362 shares during the period. Finally, Comerica Bank raised its stake in Maximus by 124.4% in the fourth quarter. Comerica Bank now owns 61,284 shares of the health services provider's stock valued at $5,290,000 after buying an additional 33,973 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently commented on MMS. Weiss Ratings downgraded Maximus from a "hold (c)" rating to a "hold (c-)" rating in a research note on Wednesday, May 20th. Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a report on Saturday. Finally, Zacks Research cut shares of Maximus from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 27th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Maximus has a consensus rating of "Hold".

Trending Headlines about Maximus

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Fiscal Q3 adjusted earnings were $2.22 per share, ahead of analyst estimates of approximately $2.20–$2.21 and up from $2.16 a year earlier. Higher margins also supported the quarter’s bottom-line performance. Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
• Positive Sentiment: The earnings beat, year-over-year EPS growth and stronger margins indicate that Maximus is maintaining profitability even as sales soften. Maximus Q3 Earnings Beat Estimates
• Neutral Sentiment: Management’s fiscal Q3 earnings call focused on the quarterly performance and updated outlook, providing investors with additional context on operating trends and the company’s expectations for the remainder of fiscal 2026. Maximus Q3 2026 Earnings Call Transcript
• Negative Sentiment: Revenue was $1.28 billion, below the $1.33 billion consensus estimate and down 5.1% year over year. The shortfall suggests softer demand or project timing is limiting growth. Maximus Fiscal Q3 Earnings Snapshot
• Negative Sentiment: Maximus reduced fiscal 2026 EPS guidance to $7.90–$8.20, below the consensus estimate of $8.43. Revenue guidance of $5.2–$5.4 billion remains broadly in line with expectations at the midpoint, but the lower profit outlook is a key overhang for MMS. Updated Maximus Fiscal 2026 Guidance

Maximus Trading Up 1.5%

Shares of MMS stock opened at $59.21 on Friday. Maximus, Inc. has a 12-month low of $52.73 and a 12-month high of $100.00. The company has a market capitalization of $3.11 billion, a PE ratio of 8.75 and a beta of 0.59. The firm has a 50 day moving average price of $58.63 and a two-hundred day moving average price of $67.46. The company has a quick ratio of 2.21, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts' consensus estimates of $2.21 by $0.01. The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The firm's quarterly revenue was down 5.1% compared to the same quarter last year. During the same quarter last year, the company earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, analysts predict that Maximus, Inc. will post 8.05 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. Maximus's dividend payout ratio (DPR) is currently 19.76%.

Maximus Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source